CLINICAL_TRIALS
trial_result
· 2008-10-15
Clinical Trial Update: A Study to Evaluate the Effectiveness of Aranesp® for Cancer Patients With Anemia [Phase 4]
Summary
Phase 4 study evaluating the effectiveness of Aranesp (darbepoetin alfa) for anemia in cancer patients; the trial has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Amgen | Conditions: Anemia, Neoplasms | Phase 4 | Status: COMPLETED